• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在一项单病例双盲试验中,Δ-9-四氢大麻酚显示出抗痉挛和镇痛作用。

Delta-9-tetrahydrocannabinol shows antispastic and analgesic effects in a single case double-blind trial.

作者信息

Maurer M, Henn V, Dittrich A, Hofmann A

机构信息

PSIN - Psychologisches Institut für Beratung und Forschung, Zürich, Switzerland.

出版信息

Eur Arch Psychiatry Clin Neurosci. 1990;240(1):1-4. doi: 10.1007/BF02190083.

DOI:10.1007/BF02190083
PMID:2175265
Abstract

A double-blind study was performed comparing 5 mg delta-9-tetrahydrocannabinol (THC) p.o., 50 mg codeine p.o., and placebo in a patient with spasticity and pain due to spinal cord injury. The three conditions were applied 18 times each in a randomized and balanced order. Delta-9-THC and codeine both had an analgesic effect in comparison with placebo. Only delta-9-THC showed a significant beneficial effect on spasticity. In the dosage of THC used no altered consciousness occurred.

摘要

进行了一项双盲研究,比较口服5毫克δ-9-四氢大麻酚(THC)、口服50毫克可待因和安慰剂对一名因脊髓损伤导致痉挛和疼痛的患者的效果。这三种情况以随机且均衡的顺序各应用18次。与安慰剂相比,δ-9-THC和可待因均具有镇痛作用。只有δ-9-THC对痉挛显示出显著的有益效果。在所使用的THC剂量下,未出现意识改变。

相似文献

1
Delta-9-tetrahydrocannabinol shows antispastic and analgesic effects in a single case double-blind trial.在一项单病例双盲试验中,Δ-9-四氢大麻酚显示出抗痉挛和镇痛作用。
Eur Arch Psychiatry Clin Neurosci. 1990;240(1):1-4. doi: 10.1007/BF02190083.
2
Lack of analgesic efficacy of oral delta-9-tetrahydrocannabinol in postoperative pain.口服Δ⁹-四氢大麻酚对术后疼痛缺乏镇痛效果。
Pain. 2003 Nov;106(1-2):169-72. doi: 10.1016/s0304-3959(03)00331-2.
3
The Cannabinoid Use in Progressive Inflammatory brain Disease (CUPID) trial: a randomised double-blind placebo-controlled parallel-group multicentre trial and economic evaluation of cannabinoids to slow progression in multiple sclerosis.大麻素用于进行性炎症性脑病(CUPID)试验:一项随机双盲安慰剂对照平行组多中心试验及大麻素延缓多发性硬化症进展的经济学评估。
Health Technol Assess. 2015 Feb;19(12):vii-viii, xxv-xxxi, 1-187. doi: 10.3310/hta19120.
4
Delta(9)-tetrahydrocannabinol, 11-hydroxy-delta(9)-tetrahydrocannabinol and 11-nor-9-carboxy-delta(9)-tetrahydrocannabinol in human plasma after controlled oral administration of cannabinoids.人体口服大麻素后血浆中的Δ⁹-四氢大麻酚、11-羟基-Δ⁹-四氢大麻酚和11-去甲-9-羧基-Δ⁹-四氢大麻酚
Ther Drug Monit. 2006 Aug;28(4):545-51. doi: 10.1097/00007691-200608000-00010.
5
Tetrahydrocannabinol Does Not Reduce Pain in Patients With Chronic Abdominal Pain in a Phase 2 Placebo-controlled Study.四氢大麻酚在一项 2 期安慰剂对照研究中不能减轻慢性腹痛患者的疼痛。
Clin Gastroenterol Hepatol. 2017 Jul;15(7):1079-1086.e4. doi: 10.1016/j.cgh.2016.09.147. Epub 2016 Oct 5.
6
Development and pharmacokinetic characterization of pulmonal and intravenous delta-9-tetrahydrocannabinol (THC) in humans.人体内肺部和静脉注射Δ⁹-四氢大麻酚(THC)的研发及药代动力学特征
J Pharm Sci. 2004 May;93(5):1176-84. doi: 10.1002/jps.20037.
7
Treatment of human spasticity with delta 9-tetrahydrocannabinol.用Δ9-四氢大麻酚治疗人类痉挛状态。
J Clin Pharmacol. 1981 Aug-Sep;21(S1):413S-416S. doi: 10.1002/j.1552-4604.1981.tb02621.x.
8
Safety and pharmacokinetics of oral delta-9-tetrahydrocannabinol in healthy older subjects: a randomized controlled trial.口服 δ-9-四氢大麻酚在健康老年受试者中的安全性和药代动力学:一项随机对照试验。
Eur Neuropsychopharmacol. 2014 Sep;24(9):1475-82. doi: 10.1016/j.euroneuro.2014.06.007. Epub 2014 Jun 28.
9
[Delta(9)-tetrahydrocannabinol and the opioid receptor agonist piritramide do not act synergistically in postoperative pain].[Δ⁹-四氢大麻酚与阿片受体激动剂匹利卡明在术后疼痛中无协同作用]
Anaesthesist. 2006 Apr;55(4):391-400. doi: 10.1007/s00101-005-0963-6.
10
The analgesic effect of oral delta-9-tetrahydrocannabinol (THC), morphine, and a THC-morphine combination in healthy subjects under experimental pain conditions.口服Δ⁹-四氢大麻酚(THC)、吗啡以及THC-吗啡组合在实验性疼痛条件下对健康受试者的镇痛作用。
Pain. 2003 Sep;105(1-2):79-88. doi: 10.1016/s0304-3959(03)00163-5.

引用本文的文献

1
Possible Role of Cannabis in the Management of Neuroinflammation in Patients with Post-COVID Condition.大麻在管理新冠后患者神经炎症中的可能作用。
Int J Mol Sci. 2024 Mar 29;25(7):3805. doi: 10.3390/ijms25073805.
2
Absorbance-Transmittance Excitation Emission Matrix Method for Quantification of Major Cannabinoids and Corresponding Acids: A Rapid Alternative to Chromatography for Rapid Chemotype Discrimination of Varieties.吸光度-透射率激发发射矩阵法用于定量主要大麻素及其相应酸:一种快速替代色谱法的方法,用于快速化学型鉴别品种。
Cannabis Cannabinoid Res. 2023 Oct;8(5):911-922. doi: 10.1089/can.2021.0165. Epub 2022 Apr 29.
3

本文引用的文献

1
AN APPROACH TO THE EVALUATION OF DRUG EFFECT DURING PSYCHOTHERAPY: A DOUBLE-BLIND STUDY OF A SINGLE CASE.心理治疗期间药物疗效评估方法:单病例双盲研究
J Nerv Ment Dis. 1964 Jul;139:20-30. doi: 10.1097/00005053-196407000-00003.
2
Statistical inference and the single case in clinical design.临床设计中的统计推断与单个病例
Psychiatry. 1960 May;23:173-84. doi: 10.1080/00332747.1960.11023214.
3
Marihuana as a therapeutic agent for muscle spasm or spasticity.大麻作为治疗肌肉痉挛或强直的药物。
A scoping review on the effect of cannabis on pain intensity in people with spinal cord injury.
关于大麻对脊髓损伤患者疼痛强度影响的范围综述。
J Spinal Cord Med. 2022 Sep;45(5):656-667. doi: 10.1080/10790268.2020.1865709. Epub 2021 Jan 19.
4
Cannabinoids for the treatment of mental disorders and symptoms of mental disorders: a systematic review and meta-analysis.用于治疗精神障碍及精神障碍症状的大麻素:一项系统评价与荟萃分析
Lancet Psychiatry. 2019 Dec;6(12):995-1010. doi: 10.1016/S2215-0366(19)30401-8. Epub 2019 Oct 28.
5
Medical Use of Cannabinoids.医用大麻素
Drugs. 2018 Nov;78(16):1665-1703. doi: 10.1007/s40265-018-0996-1.
6
Patterns of medicinal cannabis use, strain analysis, and substitution effect among patients with migraine, headache, arthritis, and chronic pain in a medicinal cannabis cohort.在一个医用大麻队列中,偏头痛、头痛、关节炎和慢性疼痛患者的医用大麻使用模式、品种分析和替代效应。
J Headache Pain. 2018 May 24;19(1):37. doi: 10.1186/s10194-018-0862-2.
7
Activation of cannabinoid CB2 receptors reduces hyperalgesia in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosis.大麻素CB2受体的激活可减轻多发性硬化症实验性自身免疫性脑脊髓炎小鼠模型中的痛觉过敏。
Neurosci Lett. 2015 May 19;595:1-6. doi: 10.1016/j.neulet.2015.04.002. Epub 2015 Apr 3.
8
Cannabinoid receptor 2: potential role in immunomodulation and neuroinflammation.大麻素受体 2:在免疫调节和神经炎症中的潜在作用。
J Neuroimmune Pharmacol. 2013 Jun;8(3):608-20. doi: 10.1007/s11481-013-9445-9. Epub 2013 Mar 8.
9
Role of cannabinoids in the treatment of pain and (painful) spasticity.大麻素在疼痛和(疼痛性)痉挛治疗中的作用。
Drugs. 2010 Dec 24;70(18):2409-38. doi: 10.2165/11585260-000000000-00000.
10
Cannabinoids as pharmacotherapies for neuropathic pain: from the bench to the bedside.大麻素类药物作为治疗神经病理性疼痛的药物:从实验室到临床。
Neurotherapeutics. 2009 Oct;6(4):713-37. doi: 10.1016/j.nurt.2009.08.002.
Psychosomatics. 1980 Jan;21(1):81, 85. doi: 10.1016/S0033-3182(80)73129-8.
4
Cannabis effect on spasticity in spinal cord injury.
Arch Phys Med Rehabil. 1982 Mar;63(3):116-8.
5
Treatment of human spasticity with delta 9-tetrahydrocannabinol.用Δ9-四氢大麻酚治疗人类痉挛状态。
J Clin Pharmacol. 1981 Aug-Sep;21(S1):413S-416S. doi: 10.1002/j.1552-4604.1981.tb02621.x.
6
The perceived effects of marijuana on spinal cord injured males.大麻对脊髓损伤男性的感知影响。
Paraplegia. 1974 Nov;12(3):175. doi: 10.1038/sc.1974.28.
7
Effect of cannabinoids on spasticity and ataxia in multiple sclerosis.大麻素对多发性硬化症中痉挛和共济失调的影响。
J Neurol. 1989 Feb;236(2):120-2. doi: 10.1007/BF00314410.
8
The analgesic properties of delta-9-tetrahydrocannabinol and codeine.δ-9-四氢大麻酚与可待因的镇痛特性。
Clin Pharmacol Ther. 1975 Jul;18(1):84-9. doi: 10.1002/cpt197518184.